MLS Clinical Research Consulting AB

Active
556761-0554Limited company (AB)Registered 2008ENEBYBERG

Key figures

12 426 kr−97,7%
Revenue 2024/25
−50,5%
Average annual change 2017/18–2024/25
01 m2 m3 m2017/182018/192019/202020/212021/222022/232023/242024/25

Key figures

2024/25

Summary: MLS Clinical Research Consulting AB

What kind of company is it?

MLS Clinical Research Consulting AB (org. no. 556761-0554) is a limited company (AB). The company was registered in 2008 and has existed for 18 years. Registered seat: Enebyberg. Industry according to Statistics Sweden: other research and experimental development on natural sciences and engineering (SNI 72109).

How is the company doing financially?

Net sales in financial year 2025 were 12 426 kr, down 97,7 % on the previous year (537 605 kr). From 2018 to 2025, net sales declined by an average of 50,5 % per year. This is the lowest net sales among the reported years (2018–2025). Financial year 2025 ended with a loss of 247 734 kr. The company was profitable in 3 of the 8 reported financial years. Employees in financial year 2025: 1 (previous year: 3). Net sales per employee were 12 426 kr. At the end of financial year 2025, total assets were 115 565 kr and equity 151 569 kr (equity ratio 131 %).

Where does the data come from and how up to date is it?

Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.

Dividend

from the annual report
2024/25

No dividend was proposed.

History
2024/250 kr
2023/240 kr
2022/230 kr
2020/21100 000 kr
2018/19100 000 kr
Summary of annual reports2018–2025
2020/212021/222022/232023/242024/25
Sales revenue1 580 146490 572879 524537 60512 426
Profit for the reporting year517 811−84 733−6 002−39 508−247 734
Retained earnings of previous periods—————
Total assets780 990513 995610 662458 778115 565
Total liabilities100 021−5 81896 851−15 526−36 004
Total equity680 969519 813513 811474 304151 569
Employees11231
Proposed dividend100 000—000

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Similar companies